Prescott's, a U.S. company specializing in refurbished microscopes, was sold to Morgan Stanley Capital Partners through Atlantic Street Capital, promising strong returns for investors amidst a growing demand for sustainable medical devices.

Information on the Target

Prescott's, a prominent player in the U.S. healthcare market, specializes in the sale of both new and refurbished microscopes. The company caters to the needs of various medical fields, particularly in neuro, ophthalmic, and ENT (ear, nose, and throat) surgery. By acquiring used equipment from hospitals and medical practices, Prescott's not only extends the lifecycle of these devices but also provides a cost-effective solution for healthcare providers looking to enhance their surgical capabilities.

With sustainability as a core principle, Prescott's exemplifies a successful business model that benefits all stakeholders involved. Sellers convert their outdated or malfunctioning equipment into revenue, while buyers enjoy significant savings on high-quality medical devices. Furthermore, Prescott's focus on refurbishing used equipment minimizes environmental impact, aligning with the growing global emphasis on resource conservation.

Industry Overview in the U.S.

The U.S. medical device industry is one of the most advanced and profitable sectors globally, driven by continual demand for innovative healthcare solutions. Microscopy, in particular, has seen sub

View Source

Similar Deals

Bambu Ventures Lemonaid Health

2026

Buyout Advanced Medical Equipment & Technology (NEC) United States of America
Heartland Dental Smile Design Dentistry

2025

Buyout Hospitals, Clinics & Primary Care Services United States of America
Sun Pharmaceutical Industries Limited Checkpoint Therapeutics, Inc.

2025

Buyout Proprietary & Advanced Pharmaceuticals United States of America
Court Square Capital and WindRose Health Investors Soleo Health

2025

Buyout Healthcare Facilities & Services (NEC) United States of America
Patient Square Capital Premier, Inc.

2025

Buyout Healthcare Facilities & Services (NEC) United States of America
Supernus Pharmaceuticals, Inc. Sage Therapeutics, Inc.

2025

Buyout Proprietary & Advanced Pharmaceuticals United States of America

Morgan Stanley Capital Partners

invested in

Prescott's

in 2023

in a Buyout deal

Disclosed details

Transaction Size: $1,400M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert